Alleghany General Hospital — Pittsburgh, Pennsylvania

Alleghany General Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15212.

Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Alleghany General Hospital has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Amyotrophic Lateral Sclerosis (ALS), Idiopathic Pulmonary Fibrosis.

Sponsors: MeiraGTx, LLC, Tanabe Pharma America, Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alleghany General Hospital?

Alleghany General Hospital has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alleghany General Hospital conducted?

Alleghany General Hospital has 9 clinical trials on record, with 5 currently active. Their work covers Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Amyotrophic Lateral Sclerosis (ALS), Idiopathic Pulmonary Fibrosis.

Is Alleghany General Hospital accredited by Crixeo Clinical Trials?

Alleghany General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alleghany General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.